• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证 IMPACT-III 问卷在法国炎症性肠病儿童中的应用。

Validation of the IMPACT-III Questionnaire in French Children With Inflammatory Bowel Disease.

机构信息

From the Sorbonne Paris Nord University, INSERM U1153, INRAE U1125, CNAM, Nutritional Epidemiology Research Team (EREN), Centre of Research in Epidemiology and Statistics - University of Paris Cité (CRESS), Bobigny, France.

Univ. Lille, INSERM, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, France.

出版信息

J Pediatr Gastroenterol Nutr. 2023 Apr 1;76(4):e71-e76. doi: 10.1097/MPG.0000000000003716. Epub 2023 Feb 2.

DOI:10.1097/MPG.0000000000003716
PMID:36735394
Abstract

OBJECTIVES

This study assessed the reliability and validity of the IMPACT-III questionnaire, a health-related quality of life (HRQoL) instrument, in French children with inflammatory bowel disease (IBD).

METHODS

Eighty-four children and adolescents (45 boys, aged 14.3 ± 2.7 years) were included in a validation study of the IMPACT-III questionnaire. Patients completed 2 questionnaires for measuring HRQoL: the IMPACT-III and the Pediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL). Internal consistency was assessed using Cronbach α. Factor analysis was performed on data from the IMPACT-III to help construct domains. Concurrent validity was assessed by calculating Spearman correlation coefficients.

RESULTS

Cronbach α for the PedsQL total score was good (0.89). The most robust factor solution was a 3-domain structure: (a) Concerns, (b) Body Image and Physical Condition, and (c) Symptoms and Socializing. All domains had good reliability (0.674-0.863). Only 2 items had to be removed. Discriminant validity was demonstrated by significant differences ( P < 0.001) in median IMPACT-III scores between inactive and active disease for the total score (83.3 vs 72.0), and for Concerns ( P < 0.002) and Symptoms and Socializing ( P < 0.001).

CONCLUSIONS

These results suggest that IMPACT-III appears to be a useful instrument for measuring HRQoL in French children with IBD.

摘要

目的

本研究评估了 IMPACT-III 问卷作为一种健康相关生活质量(HRQoL)工具在法国炎症性肠病(IBD)儿童中的可靠性和有效性。

方法

84 名儿童和青少年(45 名男性,年龄 14.3±2.7 岁)参与了 IMPACT-III 问卷的验证研究。患者完成了 2 份用于测量 HRQoL 的问卷:IMPACT-III 和儿科生活质量问卷 4.0 通用核心量表(PedsQL)。采用 Cronbach α 评估内部一致性。对 IMPACT-III 数据进行因子分析以帮助构建域。通过计算 Spearman 相关系数评估同时效度。

结果

PedsQL 总分的 Cronbach α 较好(0.89)。最稳健的因素解决方案是 3 个域结构:(a)关注,(b)身体形象和身体状况,以及(c)症状和社交。所有领域的可靠性均良好(0.674-0.863)。仅需删除 2 个项目。通过总得分(83.3 对 72.0)和关注(P<0.002)以及症状和社交(P<0.001)之间疾病不活跃和活跃时 IMPACT-III 评分中位数的显著差异证明了判别有效性。

结论

这些结果表明,IMPACT-III 似乎是一种用于衡量法国 IBD 儿童 HRQoL 的有用工具。

相似文献

1
Validation of the IMPACT-III Questionnaire in French Children With Inflammatory Bowel Disease.验证 IMPACT-III 问卷在法国炎症性肠病儿童中的应用。
J Pediatr Gastroenterol Nutr. 2023 Apr 1;76(4):e71-e76. doi: 10.1097/MPG.0000000000003716. Epub 2023 Feb 2.
2
The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease.IMPACT-III(HR)问卷:一种评估克罗地亚炎症性肠病儿童健康相关生活质量的有效工具。
J Crohns Colitis. 2013 Dec;7(11):908-15. doi: 10.1016/j.crohns.2012.12.010. Epub 2013 Jan 18.
3
Validation of an instrument to measure quality of life in British children with inflammatory bowel disease.验证一种用于测量英国炎性肠病儿童生活质量的工具。
J Pediatr Gastroenterol Nutr. 2011 Sep;53(3):280-6. doi: 10.1097/MPG.0b013e3182165d10.
4
Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children.8-12 岁儿童 PedsQLTM 4.0 通用健康相关生活质量问卷自评和代评法语版的心理测量学验证。
Health Qual Life Outcomes. 2021 Mar 4;19(1):75. doi: 10.1186/s12955-021-01714-y.
5
Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease.IMPACT-III生活质量问卷在瑞士炎症性肠病儿童中的有效性验证。
J Crohns Colitis. 2014 Jul;8(7):641-8. doi: 10.1016/j.crohns.2013.11.025. Epub 2013 Dec 15.
6
Factors associated with quality of life in Italian children and adolescents with IBD.意大利炎症性肠病儿童和青少年生活质量的相关因素。
Sci Rep. 2021 Sep 10;11(1):18076. doi: 10.1038/s41598-021-97661-1.
7
A New Domain Structure for the IMPACT-III Health-related Quality of life Tool for Pediatric Inflammatory Bowel Disease.用于儿童炎症性肠病的 IMPACT-III 健康相关生活质量工具的新域结构。
J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):494-500. doi: 10.1097/MPG.0000000000002824.
8
Parent IMPACT-III: Development and Validation of an Inflammatory Bowel Disease-specific Health-related Quality-of-life Measure.家长 IMPACT-III:炎症性肠病特异性健康相关生活质量测量的制定与验证。
J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):205-210. doi: 10.1097/MPG.0000000000002540.
9
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.儿童生活质量量表4.0:儿童生活质量量表通用核心量表第4.0版在健康人群和患者群体中的信度与效度。
Med Care. 2001 Aug;39(8):800-12. doi: 10.1097/00005650-200108000-00006.
10
Measuring health-related quality of life in Hungarian children with heart disease: psychometric properties of the Hungarian version of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales and the Cardiac Module.测量匈牙利心脏病儿童的健康相关生活质量:匈牙利版儿童生活质量问卷 4.0 通用核心量表和心脏模块的心理测量特性。
Health Qual Life Outcomes. 2010 Jan 28;8:14. doi: 10.1186/1477-7525-8-14.

引用本文的文献

1
Multilinguistic Validation of IMPACT-III Instrument to Assess Quality of Life of Indian Children with Inflammatory Bowel Disease.用于评估印度炎症性肠病儿童生活质量的IMPACT-III工具的多语言验证
Indian J Pediatr. 2025 Aug 6. doi: 10.1007/s12098-025-05690-9.
2
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.跨文化调适与验证 IMPACT-III 及 IMPACT-III-P 在西班牙家庭:来自 SEGHNP 的多中心研究。
Eur J Pediatr. 2024 Aug;183(8):3417-3430. doi: 10.1007/s00431-024-05575-7. Epub 2024 May 21.